ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2904

Utility of Untimed Single Urine Protein/Creatinine Ratio As a Substitute for the 24 Hour Proteinuria for the Assessment of Proteinuria in Systemic Lupus Erythematosus

Jorge Medina-Rosas1, Dafna Gladman2, Jiandong Su2, Arthy Sabapathy3 and Murray Urowitz2,4, 1Medicine, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 4Rheumatology, U of Toronto, Toronto Western Hospital, Toronto, ON, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: proteinuria and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To determine the
utility of an untimed Sample of Urine Protein/Creatinine ratio (S-UPCR) as a
screening test for proteinuria and its ability to accurately measure the level
of proteinuria in Systemic Lupus Erythematosus (SLE).

Methods:
Analysis
was performed on the data available from a single SLE cohort between May
2008-December 2014. Proteinuria was measured in a 24 hour urine sample
collection (24H-P) and with the S-UPCR. Based on the 24H-P, samples were
divided into: Group I: < 0.5, group II: 0.5-0.99, group III: 1-1.99, and
group IV: ≥2g/day. Correlation between 24H-P and S-UPCR was measured.
Agreement was determined by Intraclass Correlation Coefficient (ICC),
Concordance Correlation Coefficient (CCC) and Bland-Altman plot between 24H P/C
and S-UPCR. The best cut-offs for S-UPCR predicting a 24H-P of 0.5, 1.0 and 2.0
g/day were determined with the receiver operating characteristics curve.

Results:
The correlation of 24H-P and S-UPCR for all the samples overall was
high, but the correlation for groups I, II, III and IV was low-moderate. The
agreement for all urine samples overall was appropriate but poor for groups I,
II, III and IV. On the Bland-Altman plot, the dots corresponding for groups III
and IV are outside 2 Standard Deviations signifying poor agreement (Figure 1). S-UPCR
cut-offs for 24H-P of 0.5, 1.0 and 2.0 g/day were 0.08, 0.16 and 0.35 g/mmol

Conclusion:
S-UPCR
can be used as a screening test for proteinuria, and the best cut off value to
predict a 24H-P of 0.5 g/day is 0.08 g/mmol (800 mg/g). S-UPCR is not a valid
test to quantify proteinuria. The accurate level of proteinuria should be
measured by the gold standard test, 24H-P.

 

Figure
1.
Bland-Altman
plot for 24H-P/creatinine content and S-UPCR

 


Disclosure: J. Medina-Rosas, None; D. Gladman, None; J. Su, None; A. Sabapathy, None; M. Urowitz, None.

To cite this abstract in AMA style:

Medina-Rosas J, Gladman D, Su J, Sabapathy A, Urowitz M. Utility of Untimed Single Urine Protein/Creatinine Ratio As a Substitute for the 24 Hour Proteinuria for the Assessment of Proteinuria in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/utility-of-untimed-single-urine-proteincreatinine-ratio-as-a-substitute-for-the-24-hour-proteinuria-for-the-assessment-of-proteinuria-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/utility-of-untimed-single-urine-proteincreatinine-ratio-as-a-substitute-for-the-24-hour-proteinuria-for-the-assessment-of-proteinuria-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology